Cited by 91Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Towards Retinoid Therapy for Alzheimers Disease

Open access
Shudo, K., Fukasawa, H., Nakagomi, M., Yamagata, N.·2009·Current Alzheimer Research

Abstract

Alzheimers disease(AD) is associated with a variety of pathophysiological features, including amyloid plaques, inflammation, immunological changes, cell death and regeneration processes, altered neurotransmission, and agerelated changes. Retinoic acid receptors (RARs) and retinoids are relevant to all of these. Here we review the pathology, pharmacology, and biochemistry of AD in relation to RARs and retinoids, and we suggest that retinoids are candidate drugs for treatment of AD. Keywords: Alzheimer's disease, retinoid, retinoic acid receptors, inflammation, immunology, regulatory T cell, neurodegeneration

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/156720509788486581

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Vitamin A and retinoic acid administration improve Alzheimer's disease and age-related attenuation of memory/learning in mouse models, probably due to immunomodulatory effect and reduction of pro-inflammatory cytokines and chemokines production by astrocytes and microglia, as well as promotion of differentiation of neural stem cells and regeneration of neural cells.

    “Vitamin A and retinoic acid (a metabolite of all-trans-retinol) administration have been demonstrated to improve AD and age-related attenuation of memory/learning in mouse models, and this is probably due to their immunomodulatory effect and the reduction of pro-inflammatory cytokines and chemokines production by astrocytes and microglia, as well as to the promotion of differentiation of neural st”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [4]Sporn MB Roberts AB Goodman AB The Retinoids 1984 1 2 ACADEMIC PRESS, INC

Cited by

Sorted by citations

Authors
Shudo, K., Fukasawa, H., Nakagomi, M., & Yamagata, N.
Affiliations
  • Research Foundation ITSUU Laboratory (JP)
  • Institute of Medicinal Molecular Design (JP)
Corresponding author
  • Nakagomi, M.
  • Yamagata, N.
Venue
Current Alzheimer Research
Published
2009-06-01
Volume
6
Issue
3
Pages
302-311
ISSN
1567-2050 (ISSN-L)
OpenAlex
W2135650301
Cited by
91
References
163
Citations by year
2026: 3 · 2025: 4 · 2024: 11 · 2023: 3 · 2022: 7 · 2021: 2 · 2020: 7 · 2019: 8 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 6 · 2014: 5 · 2013: 8 · 2012: 5
FWCI
0.73
Type
journal article
Language
en
Open access
Locations
  • Current Alzheimer Research (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, retinoids, retinoic acid receptor, amyloid plaques, neuroinflammation, regulatory T cells, neurodegeneration, pharmacotherapy, neurotransmission
MeSH terms
Alzheimer Disease, Animals, Autoimmune Diseases, Cell Differentiation, Humans, Inflammation, Learning, Models, Biological, Retinoids, T-Lymphocytes, Antipsychotic Agents, Amyloid beta-Peptides, Receptors, Retinoic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review